I bet all of these researchers involved had a long list of candidates they'd like to test and have a very good idea what the lowest hanging fruit are, sometimes for more interesting reasons than 'it was used successfully as an inhibitor for X and hasn't been tried yet in this context' — not that that isn't a perfectly good reason. I don't think ideas are the limiting factor. The reason attention was paid to this particular candidate is because google put money down.